Explore how niacinamide supports skin barrier function and pigmentation appearance in aging skin, based on available clinical evidence and practical usage considerations.
A double-blind split-face study of a 5% niacinamide formulation reported improvements in several visible photoaging measures after 12 weeks.
Clinical and experimental evidence supports effects on visible pigmentation and epidermal barrier lipids.
The evidence base is promising but includes small studies and does not justify wrinkle-removal promises or medical claims.
Human and laboratory evidence indicates topical nicotinamide can support synthesis of ceramides and other stratum-corneum lipids involved in barrier function.
Experimental and clinical evidence indicates niacinamide can reduce melanosome transfer from melanocytes to keratinocytes, which may help the appearance of uneven pigmentation.
Small controlled clinical studies report improvements in several visible photoaging measures with consistent topical use.
Controlled facial-skin studies commonly evaluated leave-on formulations containing about 2% to 5% niacinamide.
A higher percentage is not automatically better; formula quality, frequency, and tolerability matter.
Introduce one niacinamide product at a time so irritation or pilling can be traced to a specific formula.
Patch test first if your skin is reactive or your routine already causes irritation.
Stop use and seek professional advice if burning, swelling, or a persistent rash develops.
Cosmetic niacinamide is not a substitute for medical care for persistent acne, eczema, melasma, or other skin disease.